Theraclion SA (ALTHE.PA)
Paris · EUR · Healthcare · Medical Devices
€0.65 (+5.01%) as of
Key statistics
- Market cap
- 47.96M
- Forward P/E
- 6.50
- EPS (TTM)
- -0.0900
- Dividend yield
- 0.00%
- 52-week range
- 0.4020 – 0.9300
- Beta
- 0.45
- Revenue (TTM)
- 480k
- Profit margin
- 0.00%
- Volume
- 135.09k
About Theraclion SA
Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Malakoff, France
- Employees
- 40
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.